InVivage®

Product Features

InVivage® incorporates OptiScan's latest confocal technology

Optimised for imaging cellular architecture, in clinical and research settings

Features button-controlled, miniaturised hand-held endomicroscopic probe (4mm diameter tip)

Produces real-time, sub-cellular, high resolution images at 1000x real magnification

DICOM-compatible/PACS-enabled allowing image transmission and storage

The InVivage® is currently an unapproved device and is not available for sale, pending appropriate regulatory approvals.
OptiScan is seeking interest from investigational and research organisations to further develop the clinical use possibilities as outlined below.
For expressions of interest please contact our CEO, Prof Camile Farah (CFarah@optiscan.com)

OptiScan confocal technology has the unique ability to image different tissues

Cervix

Kidney

Oral

Lung

Eye

Blood vessel

OptiScan confocal technology has excellent correlation with current gold standard histopathology

Endometrium

Mesothelioma

Oral carcinoma in situ

OptiScan confocal technology has the potential to distinguish cancer from normal tissue

Oesophagus

Oesophageal cancer

Colon

Adenocarcinoma

Breast

Ductal carcinoma

OptiScan confocal technology has the potential to distinguish normal, precancerous, and cancerous oral tissue

Normal

Pre-cancer

Cancer

Not all images above were produced using InVivage® but were produced using current or earlier OptiScan technology.
Confocal imaging is an adjunctive tool to aid in the diagnostic assessment by a health care practitioner.